ALG-000184
ALG-000184-202
Phase 2 small_molecule active
Quick answer
ALG-000184 for Chronic Hepatitis B Infection is a Phase 2 program (small_molecule) at Aligos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aligos Therapeutics
- Indication
- Chronic Hepatitis B Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active